Non-alcoholic Fatty Liver Disease Is Associated With Cardiovascular Outcomes in Subjects With Prediabetes and Diabetes: A Prospective Community-Based Cohort Study

BackgroundThere have been no studies of the effect of non-alcoholic fatty liver disease (NAFLD) on cardiovascular events (CVEs) in patients with pre-diabetes (pre-DM), and diabetes mellitus (DM). We performed a community-based cohort study to evaluate the relationship between NAFLD and CVEs in patie...

Full description

Bibliographic Details
Main Authors: Qi-Rui Song, Shuo-Lin Liu, Ya-Guang Bi, Shuo-Hua Chen, Shou-Ling Wu, Jun Cai
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.889597/full
_version_ 1817991606840590336
author Qi-Rui Song
Shuo-Lin Liu
Shuo-Lin Liu
Ya-Guang Bi
Ya-Guang Bi
Shuo-Hua Chen
Shou-Ling Wu
Jun Cai
author_facet Qi-Rui Song
Shuo-Lin Liu
Shuo-Lin Liu
Ya-Guang Bi
Ya-Guang Bi
Shuo-Hua Chen
Shou-Ling Wu
Jun Cai
author_sort Qi-Rui Song
collection DOAJ
description BackgroundThere have been no studies of the effect of non-alcoholic fatty liver disease (NAFLD) on cardiovascular events (CVEs) in patients with pre-diabetes (pre-DM), and diabetes mellitus (DM). We performed a community-based cohort study to evaluate the relationship between NAFLD and CVEs in patients with glucose metabolism disorder.MethodsWe enrolled 71,852 participants from the Kailuan study who had not experienced CVEs, after excluding alcohol abuse and other liver diseases. NAFLD was assessed using abdominal ultrasonography. Besides, participants were categorized by glucose metabolism status [normal glucose regulation (NGR), pre-DM, and DM]. All subjects were followed up for the occurrence of CVEs.ResultsDuring a median of 13.01 (0.64) years of follow-up, 6,037 CVEs occurred. NAFLD was present in 22,525 (31.3%), and compared with participants without NAFLD, those with NAFLD had a 12.3% [95% confidence interval (CI) 1.059–1.191, P < 0.001] higher risk of CVEs, after adjustment for potential confounders. The hazard ratios for patients with mild, moderate, and severe NAFLD were 1.104 (95% CI 1.035–1.179, P < 0.001), 1.149 (95% CI 1.055–1.251, P < 0.001), and 1.235 (95% CI 1.059–1.441, P < 0.001), respectively. Moreover, participants with pre-DM plus NAFLD and participants with DM plus NAFLD had 1.267-fold (95% CI 1.151–1.395, P < 0.001) and 1.829-fold (95% CI 1.666–2.008, P < 0.001) higher risks of CVEs, respectively, compared with those with NGR and no NAFLD. The addition of the combination of NAFLD and glucose metabolism status to the crude Cox model increased the C-statistic by 0.0066 (0.0053–0.0080, P < 0.001).ConclusionsNAFLD is associated with higher risks of CVEs. Moreover, NAFLD is an independent predictor of CVEs in patients with pre-DM and DM, suggesting that NAFLD may provide greater risk predictive value for patients with glucose metabolism disorder.
first_indexed 2024-04-14T01:15:29Z
format Article
id doaj.art-f964a63ed41b419fb05c914189e96e63
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-14T01:15:29Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-f964a63ed41b419fb05c914189e96e632022-12-22T02:20:54ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-04-01910.3389/fcvm.2022.889597889597Non-alcoholic Fatty Liver Disease Is Associated With Cardiovascular Outcomes in Subjects With Prediabetes and Diabetes: A Prospective Community-Based Cohort StudyQi-Rui Song0Shuo-Lin Liu1Shuo-Lin Liu2Ya-Guang Bi3Ya-Guang Bi4Shuo-Hua Chen5Shou-Ling Wu6Jun Cai7Hypertension Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease of China, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, ChinaShanghai Institute of Cardiovascular Diseases, Shanghai, ChinaDepartment of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, ChinaShanghai Institute of Cardiovascular Diseases, Shanghai, ChinaDepartment of Cardiology, Kailuan General Hospital, Tangshan, ChinaDepartment of Cardiology, Kailuan General Hospital, Tangshan, ChinaHypertension Center, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease of China, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaBackgroundThere have been no studies of the effect of non-alcoholic fatty liver disease (NAFLD) on cardiovascular events (CVEs) in patients with pre-diabetes (pre-DM), and diabetes mellitus (DM). We performed a community-based cohort study to evaluate the relationship between NAFLD and CVEs in patients with glucose metabolism disorder.MethodsWe enrolled 71,852 participants from the Kailuan study who had not experienced CVEs, after excluding alcohol abuse and other liver diseases. NAFLD was assessed using abdominal ultrasonography. Besides, participants were categorized by glucose metabolism status [normal glucose regulation (NGR), pre-DM, and DM]. All subjects were followed up for the occurrence of CVEs.ResultsDuring a median of 13.01 (0.64) years of follow-up, 6,037 CVEs occurred. NAFLD was present in 22,525 (31.3%), and compared with participants without NAFLD, those with NAFLD had a 12.3% [95% confidence interval (CI) 1.059–1.191, P < 0.001] higher risk of CVEs, after adjustment for potential confounders. The hazard ratios for patients with mild, moderate, and severe NAFLD were 1.104 (95% CI 1.035–1.179, P < 0.001), 1.149 (95% CI 1.055–1.251, P < 0.001), and 1.235 (95% CI 1.059–1.441, P < 0.001), respectively. Moreover, participants with pre-DM plus NAFLD and participants with DM plus NAFLD had 1.267-fold (95% CI 1.151–1.395, P < 0.001) and 1.829-fold (95% CI 1.666–2.008, P < 0.001) higher risks of CVEs, respectively, compared with those with NGR and no NAFLD. The addition of the combination of NAFLD and glucose metabolism status to the crude Cox model increased the C-statistic by 0.0066 (0.0053–0.0080, P < 0.001).ConclusionsNAFLD is associated with higher risks of CVEs. Moreover, NAFLD is an independent predictor of CVEs in patients with pre-DM and DM, suggesting that NAFLD may provide greater risk predictive value for patients with glucose metabolism disorder.https://www.frontiersin.org/articles/10.3389/fcvm.2022.889597/fullnon-alcoholic fatty liver diseasecardiovascular diseasediabetes mellituscoronary artery diseaseprognosis
spellingShingle Qi-Rui Song
Shuo-Lin Liu
Shuo-Lin Liu
Ya-Guang Bi
Ya-Guang Bi
Shuo-Hua Chen
Shou-Ling Wu
Jun Cai
Non-alcoholic Fatty Liver Disease Is Associated With Cardiovascular Outcomes in Subjects With Prediabetes and Diabetes: A Prospective Community-Based Cohort Study
Frontiers in Cardiovascular Medicine
non-alcoholic fatty liver disease
cardiovascular disease
diabetes mellitus
coronary artery disease
prognosis
title Non-alcoholic Fatty Liver Disease Is Associated With Cardiovascular Outcomes in Subjects With Prediabetes and Diabetes: A Prospective Community-Based Cohort Study
title_full Non-alcoholic Fatty Liver Disease Is Associated With Cardiovascular Outcomes in Subjects With Prediabetes and Diabetes: A Prospective Community-Based Cohort Study
title_fullStr Non-alcoholic Fatty Liver Disease Is Associated With Cardiovascular Outcomes in Subjects With Prediabetes and Diabetes: A Prospective Community-Based Cohort Study
title_full_unstemmed Non-alcoholic Fatty Liver Disease Is Associated With Cardiovascular Outcomes in Subjects With Prediabetes and Diabetes: A Prospective Community-Based Cohort Study
title_short Non-alcoholic Fatty Liver Disease Is Associated With Cardiovascular Outcomes in Subjects With Prediabetes and Diabetes: A Prospective Community-Based Cohort Study
title_sort non alcoholic fatty liver disease is associated with cardiovascular outcomes in subjects with prediabetes and diabetes a prospective community based cohort study
topic non-alcoholic fatty liver disease
cardiovascular disease
diabetes mellitus
coronary artery disease
prognosis
url https://www.frontiersin.org/articles/10.3389/fcvm.2022.889597/full
work_keys_str_mv AT qiruisong nonalcoholicfattyliverdiseaseisassociatedwithcardiovascularoutcomesinsubjectswithprediabetesanddiabetesaprospectivecommunitybasedcohortstudy
AT shuolinliu nonalcoholicfattyliverdiseaseisassociatedwithcardiovascularoutcomesinsubjectswithprediabetesanddiabetesaprospectivecommunitybasedcohortstudy
AT shuolinliu nonalcoholicfattyliverdiseaseisassociatedwithcardiovascularoutcomesinsubjectswithprediabetesanddiabetesaprospectivecommunitybasedcohortstudy
AT yaguangbi nonalcoholicfattyliverdiseaseisassociatedwithcardiovascularoutcomesinsubjectswithprediabetesanddiabetesaprospectivecommunitybasedcohortstudy
AT yaguangbi nonalcoholicfattyliverdiseaseisassociatedwithcardiovascularoutcomesinsubjectswithprediabetesanddiabetesaprospectivecommunitybasedcohortstudy
AT shuohuachen nonalcoholicfattyliverdiseaseisassociatedwithcardiovascularoutcomesinsubjectswithprediabetesanddiabetesaprospectivecommunitybasedcohortstudy
AT shoulingwu nonalcoholicfattyliverdiseaseisassociatedwithcardiovascularoutcomesinsubjectswithprediabetesanddiabetesaprospectivecommunitybasedcohortstudy
AT juncai nonalcoholicfattyliverdiseaseisassociatedwithcardiovascularoutcomesinsubjectswithprediabetesanddiabetesaprospectivecommunitybasedcohortstudy